期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 532, 期 2, 页码 669-676出版社
ELSEVIER
DOI: 10.1016/j.ijpharm.2017.09.010
关键词
Nanoemulsion; Iron oxide nanoparticles; Magnetic particle imaging; Atherosclerosis; Human antibodies
资金
- SVSE5 program, named ATHERANOS [ANR-13-BSV5-0018]
- French Ministry of Education Research and Technology
- Agence Nationale de la Recherche (ANR) [ANR-13-BSV5-0018] Funding Source: Agence Nationale de la Recherche (ANR)
Purpose: For early atherosclerosis imaging, magnetic oil-in-water nanoemulsion (NE) decorated with atheroma specific monoclonal antibody was designed for Magnetic Particle Imaging (MPI) and Magnetic Resonance Imaging (MRI). MPI is an emerging technique based on direct mapping of superparamagnetic nanoparticles which may advantageously complement MRI. Methods: NE oily droplets were loaded with superparamagnetic iron oxide nanoparticles of 7, 11 and 18 nm and biofunctionalized with atheroma specific scFv-Fc TEG4-2C antibody. Results: Inclusion of nanoparticles inside NE did not change the hydrodynamic diameter of the oil droplets, close to 180 nm, nor the polydispersity. The droplets were negatively charged (zeta=-30 mV). In vitro MPI signal was assessed by Magnetic Particle Spectroscopy (MPS). NE displayed MRI and MPS signals confirming its potential as new contrast agent. NE MPS signal increase with NPs size close to the gold standard (Resovist). In MRI, NE displayed R-2* transversal relaxivity of 45.45, 96.04 and 218.81 mM(-1) s(-1) for 7, 11 and 18 nm respectively. NE selectively bind atheroma plaque both in vitro and ex vivo in animal models of atherosclerosis. Conclusion: Magnetic NE showed reasonable MRI/MPS signals and a significant labelling of the atheroma plaque. These preliminary results support that NE platform could selectively image atherosclerosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据